Clinical Practice Recommendations for Pediatric Dyslipidemia
| Autor: | Casey Elkins, Katherine Bydalek, Loretta Jones, Sharon Fruh |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Adolescent Primary care Hyperlipoproteinemia Type IV Hyperlipoproteinemia Type II Young Adult Health care medicine Screening method Humans Effective treatment Sleep Hygiene Family history Child Intensive care medicine Dyslipidemias Hypolipidemic Agents business.industry Age Factors Infant Newborn Infant medicine.disease Clinical Practice Child Preschool Practice Guidelines as Topic Pediatrics Perinatology and Child Health Diet Healthy business Risk Reduction Behavior Dyslipidemia Pediatric population |
| Zdroj: | Journal of Pediatric Health Care. 33:494-504 |
| ISSN: | 0891-5245 |
| Popis: | The leading cause of mortality in the United States is atherosclerotic cardiovascular disease (ASCVD). Atherosclerotic lesions begin during childhood and can place individuals at greater risk for ASCVD. Providers play an active role in preventing the progression of risk factors and future ASCVD events through appropriate clinical management of genetic and acquired dyslipidemias in the pediatric population. Health care providers need to be aware of current recommendations related to screening for dyslipidemia, lifestyle modification strategies, pharmacologic treatment, and guidelines for ongoing monitoring. Most patients with mild to moderate dyslipidemia can be managed by a primary care provider. It is imperative that providers understand the pathophysiology, screening methods, and available treatment options to effectively manage the condition. Frequent reassessment of family history and adherence to lifestyle modifications and pharmacologic interventions is essential for effective treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect